These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

296 related articles for article (PubMed ID: 36269203)

  • 1. Tuberculosis prevalence, incidence and prevention in a south african cohort of children living with HIV.
    Anyalechi GE; Bain R; Kindra G; Mogashoa M; Sogaula N; Mutiti A; Arpadi S; Rivadeneira E; Abrams EJ; Teasdale CA
    J Trop Pediatr; 2022 Oct; 68(6):. PubMed ID: 36269203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. HIV matters when diagnosing TB in young children: an ancillary analysis in children enrolled in the INPUT stepped wedge cluster randomized study.
    Powell L; Denoeud-Ndam L; Herrera N; Masaba R; Tchounga B; Siamba S; Ouma M; Petnga SJ; Machekano R; Pamen B; Okomo G; Simo L; Casenghi M; Rakhmanina N; Tiam A
    BMC Infect Dis; 2023 Apr; 23(1):234. PubMed ID: 37069518
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tuberculosis incidence rates during 8 years of follow-up of an antiretroviral treatment cohort in South Africa: comparison with rates in the community.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2012; 7(3):e34156. PubMed ID: 22479548
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tuberculosis incidence is high in HIV-infected African children but is reduced by co-trimoxazole and time on antiretroviral therapy.
    Crook AM; Turkova A; Musiime V; Bwakura-Dangarembizi M; Bakeera-Kitaka S; Nahirya-Ntege P; Thomason M; Mugyenyi P; Musoke P; Kekitiinwa A; Munderi P; Nathoo K; Prendergast AJ; Walker AS; Gibb DM;
    BMC Med; 2016 Mar; 14():50. PubMed ID: 27004529
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalent and incident tuberculosis are independent risk factors for mortality among patients accessing antiretroviral therapy in South Africa.
    Gupta A; Wood R; Kaplan R; Bekker LG; Lawn SD
    PLoS One; 2013; 8(2):e55824. PubMed ID: 23418463
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patching the gaps towards the 90-90-90 targets: outcomes of Nigerian children receiving antiretroviral treatment who are co-infected with tuberculosis.
    Chamla DD; Asadu C; Davies A; de Wagt A; Ilesanmi O; Adeyinka D; Adejuyigbe E
    J Int AIDS Soc; 2015; 18(Suppl 6):20251. PubMed ID: 26639112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Half-life time prediction of developing first-line antiretroviral treatment failure and its risk factors among TB and HIV co-infected children in Northwest Ethiopia; multi setting historical follow-up study.
    Chanie ES; Muche AA; Gobeza MB; Alemu EM; Addis WD; Azanaw MM; Gebremariam AD; Tesfa D; Engidaw MT; Atikilit G; AbebawTiruneh S; Arage G
    BMC Pediatr; 2022 Mar; 22(1):114. PubMed ID: 35241036
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Incidence of Tuberculosis Among HIV-Positive Individuals Initiating Antiretroviral Treatment at Higher CD4 Counts in the HPTN 071 (PopART) Trial in South Africa.
    Bock P; Jennings K; Vermaak R; Cox H; Meintjes G; Fatti G; Kruger J; De Azevedo V; Maschilla L; Louis F; Gunst C; Grobbelaar N; Dunbar R; Limbada M; Floyd S; Grimwood A; Ayles H; Hayes R; Fidler S; Beyers N
    J Acquir Immune Defic Syndr; 2018 Jan; 77(1):93-101. PubMed ID: 29016524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cotrimoxazole prophylaxis and tuberculosis risk among people living with HIV.
    Hoffmann CJ; Chaisson RE; Martinson NA
    PLoS One; 2014; 9(1):e83750. PubMed ID: 24421903
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Timing of HIV diagnosis in children with tuberculosis managed at a referral hospital in Cape Town, South Africa.
    Byamungu LN; du Preez K; Walters E; Nachega JB; Schaaf HS
    Int J Tuberc Lung Dis; 2018 May; 22(5):488-495. PubMed ID: 29663952
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Drop-offs in the isoniazid preventive therapy cascade among children living with HIV in western Kenya, 2015-2019.
    Onyango DO; van der Sande MAB; Yuen CM; Mecha J; Matemo D; Oele E; Kinuthia J; John-Stewart G; LaCourse SM
    J Int AIDS Soc; 2022 Aug; 25(8):e25939. PubMed ID: 35927793
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Incidence and predictors of tuberculosis among children receiving antiretroviral therapy in the Wolaita Zone: A retrospective cohort study.
    Tekese D; Dawit D; Hawulte B; Mohammed H; Asefa F; Oljira L
    PLoS One; 2023; 18(9):e0291502. PubMed ID: 37733689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beneficial effect of isoniazid preventive therapy and antiretroviral therapy on the incidence of tuberculosis in people living with HIV in Ethiopia.
    Yirdaw KD; Jerene D; Gashu Z; Edginton ME; Kumar AM; Letamo Y; Feleke B; Teklu AM; Zewdu S; Weiss B; Ruff A
    PLoS One; 2014; 9(8):e104557. PubMed ID: 25105417
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cotrimoxazole prophylaxis decreases tuberculosis risk among Asian patients with HIV.
    Ku SW; Jiamsakul A; Joshi K; Pasayan MKU; Widhani A; Chaiwarith R; Kiertiburanakul S; Avihingsanon A; Ly PS; Kumarasamy N; Do CD; Merati TP; Nguyen KV; Kamarulzaman A; Zhang F; Lee MP; Choi JY; Tanuma J; Khusuwan S; Sim BLH; Ng OT; Ratanasuwan W; Ross J; Wong WW;
    J Int AIDS Soc; 2019 Mar; 22(3):e25264. PubMed ID: 30924281
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The incidence of tuberculosis among hiv-positive individuals with high CD4 counts: implications for policy.
    Kufa T; Chihota V; Mngomezulu V; Charalambous S; Verver S; Churchyard G; Borgdorff M
    BMC Infect Dis; 2016 Jun; 16():266. PubMed ID: 27286814
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Burden of tuberculosis in an antiretroviral treatment programme in sub-Saharan Africa: impact on treatment outcomes and implications for tuberculosis control.
    Lawn SD; Myer L; Bekker LG; Wood R
    AIDS; 2006 Aug; 20(12):1605-12. PubMed ID: 16868441
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence of tuberculosis and the need of prophylactic treatment in persons living with HIV in Stockholm during the era of anti-retroviral therapy 1996-2013.
    Norrby M; Wannheden C; Ekström AM; Berggren I; Lindquist L
    Infect Dis (Lond); 2018; 50(11-12):807-816. PubMed ID: 30362392
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of expanded antiretroviral use on incidence and prevalence of tuberculosis in children with HIV in Kenya.
    Abuogi LL; Mwachari C; Leslie HH; Shade SB; Otieno J; Yienya N; Sanguli L; Amukoye E; Cohen CR
    Int J Tuberc Lung Dis; 2013 Oct; 17(10):1291-7. PubMed ID: 24025380
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Linking HIV-infected TB patients to cotrimoxazole prophylaxis and antiretroviral treatment in India.
    Raizada N; Chauhan LS; Babu BS; Thakur R; Khera A; Wares DF; Sahu S; Bachani D; Rewari BB; Dewan PK
    PLoS One; 2009 Jun; 4(6):e5999. PubMed ID: 19543396
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effect of tuberculosis treatment on virologic and immunologic response to combination antiretroviral therapy among South African children.
    Soeters HM; Sawry S; Moultrie H; Rie AV
    J Acquir Immune Defic Syndr; 2014 Oct; 67(2):136-44. PubMed ID: 25072611
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.